Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.
Jones
D V
DV
University of Texas-M.D. Anderson Cancer Center, Houston.
Samaan
N A
NA
Sellin
R V
RV
Ajani
J A
JA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D005935:Glucagonoma / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D005472:Fluorouracil